
TIXiMED Expands Helmsley Charitable Trust Investment
TIXiMED Expands Program-Related Investment from the Helmsley Charitable Trust to Advance T1D Therapy Development TIXiMED, Inc., a clinical-stage pharmaceutical company focused on developing innovative therapies for diabetes, has announced an expansion of its program-related investment (PRI) from The Leona M.…












